Professional
Added to YB: 2025-02-17
Pitch date: 2024-12-31
TEVA [bullish]
Teva Pharmaceutical Industries Limited
+36.77%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
Market Cap
$34.2B
Pitch Price
$22.03
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.35
P/E
48.27
EV/Sales
2.92
Sector
Pharmaceuticals
Category
value
Show full summary:
The Sound Shore Fund Portfolio Holding: Teva Pharmaceutical Industries Limited
TEVA: Generic drug co w/ growing branded biz & promising pipeline. New mgmt improving margins & trials. Cheap at 4x earnings, 20%+ FCF yield. Significant discount to intrinsic value. Poor past capital allocation created opportunity.
Read full article (1 min)